Reaction

White Blood Cells Urine Positive reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,844 reports · 57 co-occurring drugs

As of the last recalculation, White Blood Cells Urine Positive appears in 1,844 FAERS reports alongside 57 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 200.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alemtuzumab	290	200.6	203.7
Dimenhydrinate	142	162.9	165.1
Cimetidine	29	34.5	34.6
Diphenhydramine Hydrochloride Capsule, Liquid Filled	62	33.9	34.0
Methylprednisolone	335	33.2	33.3
Cetirizine Hydrochloride Allergy	77	29.9	30.0
Cetirizine Hydrochloride Tablets	77	29.9	30.0
Methylprednisolone Sodium Succinate	114	29.5	29.5
Methylprednisolone Acetate	19	27.1	27.1
Esomeprazole Magnesium Capsule, Delayed Release	30	23.7	23.8
Esomeprazole Magnesium Delayed Release Capsules	30	23.7	23.8
Esomeprazole Magnesium Dihydrate	30	23.6	23.7
Diphenhydramine Hydrochloride	239	18.5	18.6
Febuxostat Tablets 40 Mg	15	16.8	16.8
Febuxostat Tablets 80 Mg	15	16.8	16.8
Cetirizine	98	15.0	15.0
Indapamide	23	14.7	14.7
Nitrofurantoin (Monohydrate/Macrocrystals)	21	14.3	14.4
Nitrofurantoin	20	13.8	13.8
Vitamin E	37	13.5	13.5
Colchicine	30	13.1	13.1
Acetaminophen Tablet Extended Release	239	12.0	12.0
Pain Reliever	239	12.0	12.0
Acetaminophen 500Mg	239	12.0	12.0
Cyanocobalamin	34	11.9	11.9
Acyclovir	107	11.2	11.2
Voclosporin	8	10.4	10.4
Aripiprazole Oral	37	10.3	10.3
Aripiprazole Orally Disintegrating	37	10.3	10.3
Ranitidine	165	10.2	10.2
Febuxostat	15	10.2	10.2
Acetaminophen	337	10.2	10.2
Tolterodine Tartrate	8	10.1	10.1
Oxybutynin	25	9.8	9.8
Torsemide	28	9.7	9.7
Baclofen	68	9.2	9.2
Oxybutynin Chloride	7	9.0	9.1
Dalfampridine	55	8.9	8.9
Modafinil	25	8.8	8.9
Cetiirizine	32	8.7	8.7
Rivastigmine	14	8.4	8.5
Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride	112	8.3	8.4
Duloxetine	50	8.3	8.3
Crisaborole	7	8.3	8.3
Ocrelizumab	43	8.0	8.0
Tapentadol Hydrochloride	22	7.5	7.5
Cetirizine Hydrochloride	104	7.5	7.5
Amantadine	9	6.6	6.6
Pazopanib Hydrochloride	15	6.3	6.3
Fesoterodine Fumarate	6	6.3	6.3
Dapagliflozin	17	6.1	6.2
Agalsidase Beta	5	6.1	6.1
Tafamidis	6	5.8	5.8
Fingolimod Hcl	34	4.5	4.5
Medroxyprogesterone Acetate	14	3.2	3.2
Lifitegrast	4	2.8	2.8
Copper	4	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.